Psilocybin and addiction
The quiet exhaustion of wanting to change, the experiences that can shift our perspective, and the research exploring a different way forward.
Sometimes, the hardest part of an addiction is how familiar it becomes.
The cigarette before you have properly opened your eyes. The drink that marks the end of another demanding day. The substance you reach for when being alone with your thoughts feels uncomfortable.
There may still be pleasure in it. There may also be a growing distance between what you want for yourself and what you keep doing.
You make promises in the morning that feel harder to hold onto at night. You negotiate. You explain it away. You wonder why something you genuinely want to change still has so much influence over your life.
If any of that feels familiar, you deserve a conversation that begins with understanding.
That is part of what makes the emerging research on psilocybin and addiction so compelling. Researchers are investigating whether psilocybin, combined with psychological support, can help people change patterns that have felt painfully difficult to interrupt.
Some findings are encouraging. Others are mixed or preliminary. Behind the numbers sits a deeply human question:
What happens when someone begins to see a different future as possible for them?
Why Wanting to Stop Can Feel So Different From Being Able To
From the outside, addiction can look like a repeated decision. Living inside it can feel much more complicated.
A substance may become connected to relief, confidence, comfort, reward, or the ability to get through an ordinary afternoon. Eventually, even the setting can become part of the pull: the drive home, the kitchen doorway, the people you spend time with.
For some people, physical dependence adds another layer. Reducing or stopping a substance can bring withdrawal symptoms, making change uncomfortable and sometimes medically dangerous. Addiction and physical dependence overlap, but they are not identical; dependence can also develop during appropriately prescribed treatment. Canada.ca
Understanding your own pattern can begin with a gentler question:
What has this been doing for me—and what has it started taking away?
You might discover that the evening drink represents permission to rest. Smoking creates a reason to step outside. A compulsive behaviour briefly quiets loneliness.
Those observations do not explain every addiction. They can, however, give you something specific to work with.
Why Psilocybin Has Become Part of the Conversation
Psilocybin is a psychedelic compound found in certain mushrooms. Its active metabolite, psilocin, acts on serotonin receptors and can profoundly change perception, emotion, and the experience of self.
Researchers are exploring whether those temporary changes can help make established patterns more open to reconsideration. The exact mechanisms behind lasting therapeutic benefits remain under investigation. Nature Medicine
The most informative addiction studies investigate psilocybin-assisted treatment: screened participants, supervised sessions, and structured psychological support.
That context matters. The results describe a treatment programme, not simply the effects of taking mushrooms.
For someone who has spent years thinking, This is just who I am, the possibility of seeing that belief differently can feel significant. Research is beginning to examine whether that shift can translate into measurable changes in behaviour.
Stories of Transformation: What Actually Seems to Change?
Transformation can sound dramatic. In people’s descriptions, it can also be surprisingly personal.
A qualitative study interviewed 12 participants from an early psilocybin smoking-cessation programme. Participants described insights into their identity and reasons for smoking, alongside experiences of connection, awe, and curiosity. They also considered preparation, trust in the research team, and the momentum of treatment important to their progress. PubMed
Those accounts suggest that change may involve more than resisting a craving. Some people begin reconsidering the place a substance occupies in their lives.
An illustrative example—not a participant quotation—might sound like this:
Smoking has been part of my day for so long that I stopped imagining a day without it. Now I can picture one.
That possibility can be moving without being a guarantee. An emotionally powerful experience does not automatically resolve withdrawal, repair relationships, or create a workable recovery plan.
It can still become something meaningful to build on.
Psilocybin and Alcohol: Encouraging Findings, With Important Nuance
Alcohol can become woven into almost every kind of occasion: celebration, stress, connection, boredom, sleep.
That familiarity can make it difficult to notice when drinking starts requiring more negotiation.
In a 2022 randomized trial, 95 adults with alcohol dependence were assigned to psilocybin or an active placebo, alongside psychotherapy. Among the 93 who received study medication, heavy drinking days accounted for 9.7% of days in the psilocybin group, compared with 23.6% in the comparison group, over the 32-week assessment period. These percentages describe days of heavy drinking, not the percentage of participants cured. PubMed
That is a meaningful result. It is also only part of the picture.
A smaller 2025 trial involving people who had recently completed alcohol withdrawal treatment found no significant advantage in abstinence duration or alcohol consumption from a single psilocybin session combined with brief psychotherapy. PMC
Together, these studies suggest that outcomes may depend on the treatment programme, the people involved, and other factors researchers still need to understand.
There is reason for interest. There is not yet a basis for promising that psilocybin will help everyone stop drinking.
If you drink heavily and regularly, get medical advice before stopping suddenly. Alcohol withdrawal can be life-threatening, and psilocybin does not replace withdrawal treatment. niaaa.nih.gov
Can Magic Mushrooms Help Someone Quit Smoking?
For many smokers, cigarettes become little landmarks throughout the day.
With coffee. After eating. During a difficult conversation. Before starting something demanding.
Research into psilocybin-assisted smoking cessation has produced promising results, including a randomized pilot trial published in 2026.
The study involved 82 smokers. Both groups received a 13-week cognitive behavioural therapy programme; one group received supervised psilocybin, while the other used nicotine patches. At six months, 40.5% of the psilocybin group met the study’s prolonged-abstinence measure, compared with 10% of the nicotine-patch group, with abstinence checked using biological testing. JAMA Network
The study was relatively small and unblinded, meaning participants knew which treatment they received. That makes expectations a potential influence and reinforces the need for larger studies.
Nevertheless, the finding gives researchers a strong reason to keep investigating.
It also leaves room for a compassionate possibility: a person who has struggled through repeated quit attempts may still respond to another form of support. Previous attempts do not determine every future outcome.
Could Psilocybin Help With Other Addictions?
The research is expanding, although the evidence is very uneven.
Cocaine: A Promising Small Randomized Trial
A 2026 randomized trial involving 40 adults with cocaine use disorder compared psilocybin with an active placebo, with both groups receiving psychotherapy.
The psilocybin group had more cocaine-abstinent days and a lower risk of returning to use during follow-up. Six of 20 participants in that group reported complete abstinence from the integration period through day 180, compared with none of 20 in the comparison group. JAMA Network
This is encouraging evidence from a small study. Larger trials are needed to determine how consistently the benefits occur and who is most likely to benefit.
Methamphetamine: Early Findings Worth Following
A 2025 pilot study enrolled 15 people with methamphetamine use disorder. Following psilocybin-assisted psychotherapy, researchers observed reductions in reported methamphetamine use during follow-up.
However, the study had no comparison group and primarily examined safety and feasibility. It cannot establish how much improvement came from psilocybin, psychotherapy, participant motivation, or other influences. PubMed
The findings support further investigation, while leaving effectiveness unsettled.
Opioids: A Developing Area With Distinct Risks
Research is exploring psilocybin in opioid-related care, including a registered pilot study examining support for tapering prescribed opioids used for chronic pain. That question differs from treating opioid use disorder, and a study registration is not proof that treatment works. ClinicalTrials.gov
For opioid use disorder, established treatments such as buprenorphine and methadone remain essential options. Psilocybin should not replace them or become a reason to discontinue treatment. After reduced opioid use, tolerance can fall, increasing overdose risk if someone returns to a previously familiar amount. Canada.ca
Medication-supported recovery is recovery. A person does not need to stop an effective treatment to make their progress more meaningful.
Gambling and Other Compulsive Behaviours
The possibility of changing entrenched patterns also raises questions about gambling, gaming, shopping, and other behaviours that can become difficult to control.
These are not interchangeable conditions, and repeated behaviour alone does not establish an addiction. Evidence from alcohol or tobacco treatment cannot simply be extended to them.
Research into gambling is emerging, including a registered pilot programme, but reliable conclusions about effectiveness remain premature up to this point.
Is It Safe to Mix Alcohol With Psilocybin?
Research into reducing drinking through psilocybin-assisted treatment does not establish that drinking during a psychedelic experience is safe.
Health Canada warns that combining mushrooms with alcohol or other substances increases the risk of adverse effects. Psilocybin itself can cause nausea, panic and impaired judgment. Adding alcohol makes an already altered state more difficult to navigate safely.
There is no established safe amount of alcohol to recommend alongside psilocybin. Avoiding the combination is the safer approach.
If someone depends on alcohol physically, the first step is medical guidance about withdrawal—not attempting to manage it with mushrooms.
The Part That Happens After the Experience
A meaningful experience may change how a person understands their life. Daily life still asks what happens next.
Who do you contact when the craving arrives? What replaces the familiar evening routine? How do you handle the argument, the lonely weekend, or the unexpected invitation?
Integration means giving an experience practical attention afterward. That might involve discussing it with a qualified therapist, examining triggers, or choosing one manageable change.
Useful reflection questions include:
- What did I notice about the role this substance plays in my life?
- What support would make change more realistic?
- Which situations need a plan?
- What is one action I can repeat this week?
- If I struggle again, who can help me respond without shame?
There is no need to force every image or feeling into a revelation. Something can feel profound and still need time, perspective, and careful discussion.
The clinical research pairs psilocybin with support for a reason. Lasting change needs somewhere to take root.
Frequently Asked Questions
Can psilocybin cure addiction?
Research supports potential benefits for some addictions within structured treatment, but it does not establish a universal or permanent cure. Studies vary, and long-term outcomes require further investigation.
Which addictions have the most encouraging evidence?
Alcohol and cigarette smoking have several important studies. A small randomized cocaine trial is also encouraging. Evidence for methamphetamine is preliminary, while cannabis, opioid-related applications, and gambling remain developing research areas.
Is psilocybin itself addictive?
Psilocybin has relatively low dependence potential, and tolerance can develop quickly. That does not make repeated use harmless or prevent someone from developing an unhealthy relationship with the experience. Canada.ca
Does a difficult trip mean healing is happening?
No. Distress is not proof of therapeutic progress. A difficult experience may need support, and there is no requirement to interpret suffering as beneficial.
A Future That Feels Possible Again
Perhaps the most compelling part of this research is the possibility that a deeply familiar pattern can become less fixed.
That matters when you have begun to confuse your struggle with your identity.
You are allowed to want relief. You are allowed to feel uncertain about change. You are allowed to need more support than you first expected.
Psilocybin research offers reasons for curiosity and, in some areas, measured hope. The wider invitation is available whether psychedelics ever become part of your life: to understand what keeps the cycle going, seek support that fits, and leave room for a different outcome.
You do not have to know exactly what recovery will look like before taking a step toward it. Believe in yourself.
Beyond the Research: What Change Felt Like to the People Who Experienced It
Statistics can tell us how many people drank less or stopped smoking. They cannot fully describe what it feels like when something that once occupied so much of your life begins to lose its hold.
For that, it helps to listen to the people themselves.
In interviews, research accounts, and online discussions, some participants describe changes that reach beyond cravings: feeling closer to loved ones, becoming less critical of themselves, or finally imagining a future that looks different from their past.
These are selected positive experiences, rather than a promise of what anyone else will feel. Some come from documented study participants; others are anonymous personal reports. Together, they bring a human perspective to the research.
Kathy’s Experience: When Cigarettes Began to Feel Smaller
Kathy Conneally participated in the original Johns Hopkins smoking-cessation study involving 15 people. She had tried quitting through several approaches before joining the programme.
What she described afterward was a change in perspective. Smoking began to seem insignificant compared with the things that mattered to her. At the time of her interview, she reported being able to spend time around people who smoked without feeling drawn to join them.
Her sessions were largely about thoughts and feelings, rather than elaborate visions. She also described a broader improvement in how everyday life felt.
Kathy’s account offers a glimpse of what it might mean for a familiar habit to occupy less emotional space. The cigarette was still something she recognized; its importance had changed. www.wmar2news.com
Jon’s Experience: Imagining Life Without Alcohol
Jon Kostas, a participant in the NYU alcohol-use-disorder trial, described a memorable image during a supervised session: a liquor bottle standing in a desert, then dissolving into the sand.
He interpreted it as a symbol of his addiction leaving him. The experience gave him a powerful sense that recovery was possible.
In his PBS interview, Jon reported stopping drinking after his first dosing session and described the change in deeply personal terms:
“I live without the addiction, which I never thought would be possible.”
His account is especially striking because of the future he had previously struggled to imagine. He described reaching a place where alcohol no longer occupied the same role in his life.
That was his individual experience within a treatment programme that included psychotherapy. It does not establish that everyone will experience the same relief, but it helps explain why this research carries so much emotional significance. www.pbs.org
Watch or read Jon’s PBS interview
Mary Beth’s Experience: Feeling Connected Again
Before enrolling in the alcohol study, Mary Beth Orr reported drinking five or six drinks each evening, with more on weekends.
She described experiences during treatment that helped her feel less alone. In her 2022 interview with the Associated Press, she reported having stopped drinking for two years before returning to occasional wine.
Her explanation was simple:
“It made alcohol irrelevant and uninteresting to me.”
She also described a stronger connection to her children and loved ones, which reduced the appeal of being alone with alcohol.
Her story brings attention to something easily missed in a discussion focused only on consumption: what a person feels drawn toward as drinking becomes less central. For Mary Beth, relationships became an important part of that change. www.click2houston.com
Learning to Respond to Cravings With Compassion
Published interviews with alcohol-study participants offer another perspective: some described changes in how they treated themselves.
One participant imagined their craving as a small, distressed animal. During the experience, they pictured calming and caring for it. This became a personal image of meeting an urge with gentleness.
Another described seeing their father’s life become entangled in a web representing alcohol and suffering. They then imagined themselves becoming caught in a similar pattern before shaking free. The experience brought feelings of compassion toward both their father and themselves.
A third participant described recognizing the severity of their self-judgment and discovering that they could take a kinder perspective.
These accounts suggest a possible emotional dimension of recovery: being able to acknowledge pain and harmful patterns without making self-punishment the only response. They describe participants’ interpretations of their experiences; they do not prove that a particular image or insight produces lasting recovery. pmc.ncbi.nlm.nih.gov
Read the research interviews on self-compassion and alcohol use
Lisa’s Experience: A Quieter Relationship With Herself
A clinical case report describes a participant given the pseudonym Lisa. During the treatment programme, she reported greater self-acceptance, less negative self-talk, and an improved ability to manage stress. Alcohol became less appealing, and she made more time for social connection, relaxation, and meditation.
There is an important detail in interpreting her story: when the report was published, researchers had not yet revealed whether her first two sessions contained psilocybin or the comparison medication. Her optional third session was confirmed as psilocybin.
Her account therefore illustrates meaningful change within the study, while leaving uncertainty about the specific contribution of the earlier medication sessions. www.frontiersin.org
Read Lisa’s clinical case report
An Online Account: “I Have Almost No Desire”
The conversation also extends beyond formal interviews.
In a Reddit discussion of the alcohol trial, one commenter explicitly stated that they had participated in the study. They wrote:
“I have not had a drink since my first medication session (almost 3 years). It was like a switch. I have almost no desire.”
They described the experience as life-changing while acknowledging that it would not be the same for everyone.
Their identity and participation cannot be independently verified from the comment. It should therefore be understood as a self-reported participant account, rather than a confirmed research outcome. Even with that limitation, it captures the kind of relief some people describe: a reduction in the desire itself. www.reddit.com
Feeling More Whole After Quitting Smoking
Written comments from the early smoking study add another layer. Among 12 participants whose abstinence was biologically verified at six months, descriptions included gratitude, forgiveness, connection, and a renewed interest in spiritual life.
One participant described:
“Feeling complete as a person and physically a part of all things.”
These comments show how personally meaningful the sessions could feel. They do not establish that spiritual experiences are necessary for recovery or explain why every participant stopped smoking. pmc.ncbi.nlm.nih.gov
Read the smoking-study participants’ comments in Table 2
Across these stories, change takes different forms. Someone feels less interested in alcohol. Someone reconnects with family. Someone notices a craving without immediately condemning themselves for having it.
What makes these accounts moving is the possibility they describe: a familiar struggle can begin to feel different. Within that change, a person may find more room to choose, reconnect, and build a life they want to be present for.
Sources, Research & Personal Stories
- Understanding substance use — Health Canada
- The science of psychedelic medicine — Nature Medicine
- Smoking cessation: Participant accounts
- Psilocybin and alcohol use disorder — 2022 trial
- Alcohol relapse prevention — 2025 trial
- Alcohol use disorder and withdrawal — NIAAA
- Psilocybin versus nicotine patches — Smoking cessation trial
- Psilocybin and cocaine use disorder
- Psilocybin and methamphetamine use disorder
- Psilocybin-assisted therapy for tapering opioid medication
- Opioid use disorder and treatment — Health Canada
- Psilocybin: Effects, risks, and dependence — Health Canada
- Kathy’s smoking-cessation experience — WMAR
- Jon’s experience — PBS: Can Psychedelics Cure?
- Mary Beth’s experience — Associated Press
- Self-compassion and emotional regulation: Alcohol-study interviews
- Lisa’s clinical case report — Frontiers
- Self-reported alcohol-study participant — Reddit discussion
